Trial intelligence / Profile preview

MEBO vs Diltiazem for Acute Anal Fissure

NCT04153032Phase 2Recruiting

Sponsor
American University of Beirut Medical Center
Start
Dec 2019
Primary completion
Jan 2026
Modality
Botanical drug
Countries
1
01

Overview

A Phase 2 trial of MEBO Moist Burn Ointment in anal fissure, sponsored by American University of Beirut Medical Center. Started Dec 2019; status: recruiting.

02

Drugs

MEBO Moist Burn Ointment
03

Conditions

anal fissure

Beyond the preview

Go deeper on NCT04153032.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04153032.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call